Lataa...
Targeting Huntington’s disease through histone deacetylases
Huntington’s disease (HD) is a debilitating neurodegenerative condition with significant burdens on both patient and healthcare costs. Despite extensive research, treatment options for patients with this condition remain limited. Aberrant post-translational modification (PTM) of proteins is emerging...
Tallennettuna:
Päätekijä: | |
---|---|
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
Springer-Verlag
2011
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3365382/ https://ncbi.nlm.nih.gov/pubmed/22704341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13148-011-0025-7 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|